Aktie SUPRIYA SUPRIYA LIFESCIENCE LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Supriya Lifescience Limited

Aktien

SUPRIYA

INE07RO01027

SUPRIYA

Schlusskurs NSE India S.E.
Andere Börsenplätze
 00:00:00 01.07.2024 		% 5 Tage % 1. Jan.
398 INR +2,68 % Intraday Chart für Supriya Lifescience Limited +1,49 % +26,45 %
14.06. Supriya Lifescience CEO geht in den Ruhestand MT
14.06. Supriya Lifescience Limited kündigt den Rücktritt von Rajeev Kumar Jain als Chief Executive Officer an CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Supriya Lifescience CEO Retires
Supriya Lifescience Limited Announces Resignation of Rajeev Kumar Jain as Chief Executive Officer
Supriya Lifescience Limited Approves Executive Changes
Supriya Lifescience Limited Recommends Final Dividend for the Fiscal 2024
Supriya Lifescience Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
Supriya Lifescience Limited Reports Earnings Results for the Full Year Ended March 31, 2024
Supriya Lifescience Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Supriya Lifescience Limited Announces Approval of Capital Expenditure at Ambernath Site for CDMO Facility
Supriya Lifescience Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Supriya Lifescience Gets Brazil's Health Authority's GMP Certification for Site in India
Supriya Lifescience Ltd Signs Agreement with Kalinga Institute of Technology for Further Development of Wound Healing Gel
Supriya Lifescience Ties Up with Kalinga Institute for Oral Cancer Detection Kit
Supriya Lifescience Ltd Collaborates with Kalinga Institute of Industrial Technology to Develop One of its Kind Oral Cancer Detection Kit Named Quickblue Oral Kit
Supriya Lifescience Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Supriya Lifescience Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Supriya Lifescience Ltd. and Plasma Nutrition, Inc Announce Collaboration in Protein Technology
Supriya Lifescience Limited Executes A Long-Term Supply and Sales Agreement with A Leading Company in Europe for the Supply of Active Pharmaceutical Ingredient
Supriya Lifescience Limited Recommends Final Dividend for the Year Ended March 31, 2023
Supriya Lifescience Names President for Business Development, Strategy and R&D
Supriya Lifescience Limited Reports Earnings Results for the Full Year Ended March 31, 2023
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. SUPRIYA Aktie
  4. Nachrichten Supriya Lifescience Limited
  5. Andere Sprachen